More interestingly, MDM2 and NFAT1 were shown to be simultaneously overexpressed in many HCC patients, which was correlated with poor prognosis in those HCC patients as determined by the OS and RFS rates at 1, 3, 5, and 7 years post-hepatectomy [37]. This evidence concerns the gene NFATC2 and hepatocellular carcinoma.